https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2026/The-data-layer-for-AI-enabled-drug-discovery/default.aspx hourly 2026-09-16T09:42:49-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2026/Q1-2027-Earnings-Presentation/default.aspx hourly 2026-09-20T02:19:46-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2026/Q4-2026-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2026/Discovery-to-Clinic--2026-jnL7ZFpz2t/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2026/Q3-2026-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2026/Where-biology-becomes-computable-2026-LtPceYpGWZ/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Q1-2026-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Q2-2026-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Where-biology-becomes-computable---Bio-Native-AI-engineered-to-reason-the-way-biology-stores-meaning-2025-zxp_WWmgUs/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Accelerating-Drug-Discovery-through-First-End-to-End-Bio-Native-AIPlatform-2025-LuwntNBt3R/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Q4-2025-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/LENSai-Empowering-Diversity-Driven-Discovery-Intelligent-Lead-Selection-and-Optimization-2025-LZO2PX_phl/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Evolving-the-Intersection-of-AI-Data-and-Biology-for-Drug-Discovery-2025-yA66ytQ3Sl/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/In-Silico-Driven-Strategies-to-Unlock-the-Therapeutic-Potential-of-Rabbit-Derived-Antibodies-2025-VuDeHCDqcT/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Evolving-the-Intersection-of-AI-Data-and-Biology-for-Drug-Discovery-2025-u-ZHzMsg3H/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Evolving-the-Intersection-of-AI-Data-and-Biology-for-Drug-Discovery-2025-ZcX3KTqtpK/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/ImmunoPrecise-Antibodies-Accelerates-Therapeutic-Discovery-with-Vultr-2025-xkRN00YZQP/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Q3-2025-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/HYFT-Technology-AI-Bio-Native-Frameworkfor-Drug-Discovery-2025-MYp3xcfOoM/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2025/Evolving-the-Intersection-of-Biology-Intelligence-and-Data-for-Drug-Discovery-2025-k5-nnKy31c/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Q2-2025-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/TECHday-2024-2024-c8Wx7qqHBz/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/IPA-IR-Deck-09202024-2024-e1Yk3HfnWt/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Q1-2025-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Q4-2024-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Funneling-while-maintaining-functional-diversity-Strategies-for-amplified-lead-selection-2024-KyR7sbrr67/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Unlocking-the-future-of-medicine-Advancing-de-novo-in-silico-drug-discovery-2024-bGkFeA3Zmq/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Q3-2024-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/LENSai---Integration-of-wet-lab-and-in-silico-technologies-2024-R14vrpea4e/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2024/Talem-Therapeutics-Pipeline-2024-HH5XfjKDdK/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/Q2-2024-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/Solving-the-Information-Integration-Dilemma-IID-in-life-sciences-2023-LiyLDM2XlC/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/Jefferies-Healthcare-Conference-2023-2023-oTOScB6qYT/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/Capabilities-Deck---June-2023-2023-DPeqxe9Yyk/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/Unleashing-the-potential---Investor-Report-2023-oh7-AlbMvy/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/IpA-Corporate-Presentation-2023-MricH281zs/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/Q3-2023-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2023/IpA-Corporate-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2022/Q2-2022-Earnings-Presentation/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/presentation/presentation-details/2022/ImmunoPrecise-Antibody-Engineering--Therapeutics-Webinar/default.aspx hourly 2026-08-17T10:05:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2026/MindWalk-Reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-2027-on-September-14-2026/default.aspx hourly 2026-09-25T05:23:17-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2026/MindWalk-Reports-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Full-Fiscal-2026-on-July-22-2026/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2026/MindWalk-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2026-on-March-12-2026/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/MindWalk-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2026-on-December-15-2025/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/MindWalk-to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2026-on-September-15-2025-2025-4kT7Ase2Mo/default.aspx hourly 2026-09-17T02:40:14-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Full-Fiscal-Year-2025-on-July-29-2025-2025--pxtmZqzVc/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/ImmunoPrecise-Antibodies-IPA-to-Present-at-Maxim-Groups-2025-Virtual-Tech-Conference-2025-OPpu8O8oF_/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/ImmunoPrecise-Antibodies-IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2025/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/Experience-Bio-Native-AI-at-NVIDIA-GTC-2025-BioStrand--Vultr-Unveil-LENS-Powered-by-HYFT-2025-H_ghBkYaYx/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/NVIDIA-GTC-2025-the-conference-for-the-era-of-AI-2025-QG_c_Or0TC/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/Sequire-Investor-Summit-2025-IO9RusO24t/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2025/Join-IPA-at-the-prestigious-JPM-2025-2025-UKJb9SqKK0/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/AIDD-2024-Fireside-Chat-2024-6Q6Zxfa2cv/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/IPA-to-Present-at-The-Benchmark-Companys-Upcoming-Discovery-One-on-One-Investor-Conference-2024-aYx8Mhzr7X/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2025-on-December-10-2024-2024-NgexQmyBhH/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/AI-Driven-Drug-Discovery-Summit-USA-2024-ttu8xo-NOp/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/IPA-reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2025/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/ImmunoPrecise-Antibodies-to-Participate-at-HC-Wainwrights-26th-Annual-Global-Investment-Conference-in-New-York-2024-oOdCQ9XVLw/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fiscal-Year-2024/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2024/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2024/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2024/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/IMMUNOPRECISE-ANTIBODIES-LTD-Annual-General-Meeting-of-Shareholders-2023-2023-TdNmoREF0i/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2024/default.aspx hourly 2026-09-17T02:55:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/Radius-Research---Immunoprecise-Antibodies-IPA-CEO-Jennifer-Bath-outlines-its-AI-initiatives-in-Driving-Growth-2023-Yb8OISK1z7/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-Fiscal-Year-2023/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/Jefferies-Healthcare-Conference-2023-2023-l5S-ddDZ6B/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2023/default.aspx hourly 2026-09-17T02:56:42-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2022/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2023/default.aspx hourly 2026-09-17T02:23:04-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2021/ImmunoPrecise-LifeScience-Webinar/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2020/ImmunoPrecise-Antibody-Engineering--Therapeutics-Webinar/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/events-and-presentations/event-details/2020/ImmunoPrecise-Gravitas-Healthcare-Day-Presentation/default.aspx hourly 2026-08-17T10:01:56-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-NASDAQ-HYFT-Enterprise-AI-Has-Found-Its-Ontology-Layer--Biology-Needs-One-Grounded-in-Biological-Function/default.aspx hourly 2026-10-06T08:46:08-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Appoints-Kim-Remizowski-to-Board-of-Directors-as-Independent-Director/default.aspx hourly 2026-10-01T08:46:06-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Brings-OpenFold3-into-Production-in-Minutes-with-AMD-Inference-Microservices-on-Vultr-Kubernetes-Engine/default.aspx hourly 2026-09-21T08:46:05-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Reports-21-Revenue-Growth-and-Gross-Margin-Expansion-to-59-in-Fiscal-First-Quarter-2027/default.aspx hourly 2026-09-17T07:43:08-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Lands-Binding-Commitment-for-US30-Million-Unsecured-Credit-Facility-to-Fund-Biologics-Programs-and-Commercial-Expansion/default.aspx hourly 2026-09-14T08:46:11-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-to-Participate-in-the-H-C--Wainwright-28th-Annual-Global-Investment-Conference/default.aspx hourly 2026-09-10T08:34:04-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2027-on-September-14-2026/default.aspx hourly 2026-09-08T08:30:17-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Showcases-ReefIQ-for-AI-Drug-Discovery-at-AMD-Advancing-AI/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--Reports-Fiscal-2026-Results-Revenue-Up-46-as-the-Company-Completes-Its-Pivot-to-Bio-Native-AI-Infrastructure/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Full-Fiscal-Year-2026-on-July-22-2026/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--NASDAQ-HYFT-Added-to-the-Russell-3000E-Index-Expanding-Institutional-Investment-Opportunity/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-NASDAQ-HYFT-Files-Patent-for-High-Dimensional-Biological-Data-Architecture-Powering-AI-Drug-Discovery/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-NASDAQ-HYFT-CEO-Dr--Jennifer-Bath-to-Join-Absci-NASDAQ-ABSI-and-a-Leading-AI-Compute-Provider-on-Jones-AI-Day-Panel-on-the-Future-of-AI-Drug-Discovery/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--NASDAQ-HYFT-Launches-ReefIQ-a-Biological-Context-Layer-for-AI-Drug-Discovery/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalks-Preclinical-Dengue-Data-Support-a-HYFT-Computational-Prediction-Immunogens-Designed-on-the-Predicted-Target-Elicited-Cross-Reactive-Antibodies-Against-Antigens-of-All-Four-Dengue-Serotypes-Reproduced-Across-Two-Independent-Campaigns/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/Prklinische-Dengue-Daten-von-MindWalk-sttzen-eine-rechnergesttzte-HYFT-Vorhersage-Auf-das-vorhergesagte-Zielmolekl-ausgelegte-Immunogene-erzeugten-kreuzreaktive-Antikrper-gegen-Antigene-aller-vier-Dengue-Serotypen/default.aspx hourly 2026-08-17T03:51:36-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Deploys-Pandemic-Response-Platform-via-HYFT-Technology-as-Ebola-and-Hantavirus-Outbreaks-Expose-the-Limits-of-Strain-Specific-Coverage/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/The-Biology-Came-First-/default.aspx hourly 2026-09-25T05:23:27-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--Reports-Q3-Fiscal-2026-Financial-Results/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Announces-B-Cell-Llama-a-Nanobody-Discovery-Platform-Designed-for-the-Bispecific-and-Cell-Therapy-Era/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-stellt-B-Cell-LlamaTM-vor--eine-Nanobody-Discovery-Plattform-fr-das-bispezifische-und-zelltherapeutische-Zeitalter/default.aspx hourly 2026-08-17T03:51:36-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Holdings-Corp--to-Report-Third-Quarter-Fiscal-Year-2026-Financial-Results-on-March-12-2026/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-setzt-HYFT-Technologie-zur-Erkennung-funktionaler-Adjazenz-mit-Bezug-zu-Portfoliorisiken-bei-KI-designten-Therapeutika-ein/default.aspx hourly 2026-08-17T03:51:36-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Applies-HYFT-Technology-to-Detect-Functional-Adjacency-Linked-to-Portfolio-Risk-in-AI-Designed-Therapeutics/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Validates-Platform-Precision-with-Breakthrough-Discovery-Targeting-Pathogenic-TDP-43-in-Neurodegenerative-Disease/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-validiert-die-Przision-seiner-Plattform-mit-einer-bahnbrechenden-Entdeckung-zur-pathogenen-Form-des-Schlsselproteins-TDP-43-bei-neurodegenerativen-Erkrankungen/default.aspx hourly 2026-08-28T12:45:52-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/REPEATMindWalk-Advances-Universal-Influenza-Program-with-a-Breakthrough-Functional-Insight/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-treibt-universelles-Influenza-Programm-mit-bahnbrechender-funktioneller-Erkenntnis-voran/default.aspx hourly 2026-08-17T03:51:36-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2026/MindWalk-Advances-Universal-Influenza-Program-with-a-Breakthrough-Functional-Insight/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Reports-Record-Growth-and-Announces-Strategic-Progress-on-Its-AI-Asset-Pipeline/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Holdings-Corp--to-Report-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2026-on-December-15-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-CTO-Dr--Dirk-Van-Hyfte-to-Join-Fireside-Chat-at-AI-Drug-Discovery--Development-Summit-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Appoints-R--Scott-Areglado-as-Chief-Financial-Officer-to-Strengthen-Financial-Leadership-and-Support-Growth-Strategy/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Appoints-Dr--Thomas-W--Lynch-as-Chief-Business-Officer-to-Accelerate-Commercial-Expansion/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Announces-Share-Repurchase-Program/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Advances-AI-Designed-GLP-1-Program-with-First-in-Class-Dual-Pathway-Regimen-for-Aging-and-Longevity/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-Holdings-Corp--formerly-ImmunoPrecise-Antibodies-Reports-Record-7-6-Million-Quarterly-Revenue-45-Growth-Margin-Expansion-Narrowed-Losses-and-Strengthened-Balance-Sheet/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/MindWalk-to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2026-on-September-15-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Rebrands-as-MindWalk-Announces-NASDAQ-Ticker-Change-to-HYFT/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-to-Participate-at-H-C--Wainwrights-27th-Annual-Global-Investment-Conference-in-New-York/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Advances-AI-Discovered-and-Developed-Universal-Dengue-Vaccine-Initiative-Moves-into-Preclinical-Antibody-Generation/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Ltd--Divests-Netherlands-Facilities-to-AVS-Bio-to-Accelerate-Bio-Native-AI-Innovation/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-IPA-Reports-Full-Fiscal-Year-2025-Results-Record-Fourth-Quarter-Revenue-and-Record-Fourth-Quarter-Adjusted-EBITDA/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Releases-New-Findings-Showing-LENSai-Quickly-Flags-Anti-Drug-Antibody-RiskLong-Before-the-Clinic/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Appoints-Healthcare-Data-Visionary-Jeff-Fried-to-Advisory-Board/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Full-Fiscal-Year-2025-on-July-29-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Appoints-Industry-Veteran-Jon-Lieber-to-Board-of-Directors/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Validates-LENSai-Epitope-Mapping-Platform-Across-Broad-Range-of-Unseen-Therapeutic-Targets-Beyond-Training-Data/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Advances-Universal-Dengue-Vaccine-Confirming-Safety-Immune-Activation-and-Structural-Stability-Using-its-LENSai-Platform-Powered-by-Patented-HYFT-Technology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/AI-Designed-GLP-1-Peptides-from-ImmunoPrecise-Antibodies-Surpass-Semaglutide-in-Receptor-Activation-Studies/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Announces-AI-Driven-Breakthrough-in-Universal-Dengue-Vaccine-Discovery/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Engages-CORE-IR-to-Enhance-Investor-Engagement-Efforts/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-IPA-to-Present-at-Maxim-Groups-2025-Virtual-Tech-Conference/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/IPAs-LENSai-Platform-Delivers-X-RayLevel-Epitope-Mapping-Insights-in-Hours-Matching-Gold-Standard-Methods-with-Greater-Speed/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Highlights-Alignment-of-Proprietary-AI-Driven-Platform-LENSai-with-FDAs-Shift-to-Non-Animal-Testing-Methods/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-and-a-Global-Biotechnology-Leader-Enter-into-a-USD-8M-10M-Partnership-for-the-Development-of-Novel-Cancer-Therapeutics/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/IPA-to-Reschedule-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2025-on-March-28-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2025-on-March-13-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/IPA-and-RIBOPRO-Partner-to-Advance-mRNA-Driven-Antibody-Discovery-Unlocking-New-Frontiers-in-Immunotherapy/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Announces-Key-Leadership-Changes/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Announces-Transfer-to-Nasdaq-Capital-Market-and-Extension-of-Bid-Price-Compliance-Period/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-IPA-Announces-Completion-of-At-the-Market-Equity-Offering-and-Full-Conversion-of-Yorkville-Debenture/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/IPA-ImmunoPrecise-Antibodies-Pioneers-AI-Designed-GLP-1-Therapies-A-Potential-New-Chapter-in-Diabetes-Treatment/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2025/ImmunoPrecise-Antibodies-Realigns-Pipeline-Strategy-Empowering-Drug-Discovery-with-AI-and-First-Principles-Innovation/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-Announces-Resignation-of-Chief-Financial-Officer/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-IPA-Demonstrates-Strong-Market-Confidence-with-Insider-Share-Purchases/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-to-Present-at-The-Microcap-Conference-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-to-Present-at-The-Benchmark-Companys-Upcoming-Discovery-One-on-One-Investor-Conference/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2025-on-December-10-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/20-Billion-Market-Breakthrough-IPA-Pioneers-High-Impact-Antibody-Development-for-Next-Generation-ADC-Cancer-Therapies/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-to-Host-TECHDAY-Cutting-Edge-AI-and-Biologics-Innovation/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Advances-Anti-Aging-Research-with-Mayo-Clinic-Study-Poised-to-Tap-into-81-Billion-Market-with-AI-Technology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-to-Participate-at-the-AI-Driven-Drug-Discovery-Summit-USA-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-Celebrates-Nobel-Prize-in-Chemistry-Advances-in-AI-Powered-Protein-Design/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Subsidiary-Signs-Material-Transfer-Agreement-with-Biotheus/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-Advances-Therapeutic-Innovation-with-Groundbreaking-Rabbit-Antibody-Developments/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2025/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2025-on-September-16-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-to-Participate-at-H-C--Wainwrights-26th-Annual-Global-Investment-Conference-in-New-York/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-Receives-Nasdaq-Notification-Regarding-Minimum-Bid-Requirements/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-Successfully-Engineers-in-silico-Antibodies-to-Elusive-Tumor-Protein-Using-Its-Patented-LENSai-Technology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-IPA-Reports-Financial-Results-and-Business-Updates-for-Fourth-Quarter-and-Full-Fiscal-Year-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-to-Reschedule-Financial-Results-and-Recent-Business-Highlights-Report-for-Fourth-Quarter-and-Fiscal-Year-End-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Announces-Financing-Agreement-with-Yorkville-Advisors-Global-LP-of-up-to-3-0-Million-Aggregate-Principal-Amount-of-Convertible-Debentures/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Fiscal-Year-End-2024-on-July-25th-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Appoints-Kristin-Taylor-as-Chief-Financial-Officer/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPAs-Subsidiary-BioStrand-and-PGxAI-Announce-Strategic-Collaboration-to-Develop-First-In-Class-AI-Model-for-Pharmacogenomics-Recommendations-Using-LENSai/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/ImmunoPrecise-Antibodies-Ltd--Subsidiary-BioStrand-Receives-Prestigious-2024-Impact-Award-for-Groundbreaking-LENSai-Technology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/BioStrand-ImmunoPrecise-Antibodies-Subsidiary-Announces-Immediate-Commercial-Offering-of-Groundbreaking-Software-with-Customizable-Interface-for-AI-Driven-Drug-Discovery/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPAs-Subsidiary-BioStrand-Announces-Advanced-Large-Language-Model-LLM-for-Electronic-Health-Records-EHR/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/InterSystems-and-IPAs-Subsidiary-BioStrand-Collaborate-to-Unveil-the-Innovative-Integration-of-Vector-Search-with-LENSai-for-AI-Driven-Healthcare-Applications/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-Acquires-the-Carterra-LSA-Instrument-to-Enhance-Antibody-Discovery-and-Bolster-Its-AI-Developments/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPAs-subsidiary-BioStrand-Unveils-Major-Breakthrough-in-Life-Sciences-with-Advanced-Foundation-AI-Model-Utilizing-LLM-Stacking-and-HYFT-Technology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2024/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2024-on-March-14-2024/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2024/default.aspx hourly 2026-08-17T10:00:09-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Announces-Closing-of-1-265-Million-Public-Offering-of-Common-Shares/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Announces-Pricing-of-1-1-Million-Public-Offering-of-Common-Shares/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Announces-Proposed-Public-Offering-of-Common-Shares/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecise-Antibodies-Ltd--Announces-Key-Board-and-Board-Committee-Chair-Appointments-and-Second-Quarter-2024-Earnings-Release-Call/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/BioStrand-Unveils-a-Revolutionary-Approach-to-Biological-Sequence-Retrieval-A-Fusion-of-Natural-Language-Processing-and-Database-Research/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPAs-Subsidiary-BioStrand-Provides-an-Update-on-LENSai-2023-xcA0JQr_0e/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Provides-Update-on-Growth-Strategy-and-Recent-Share-Price-Movement/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecise-Antibodies-Announces-CFO-Transition/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2024/default.aspx hourly 2026-08-17T10:00:09-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2024-on-September-14-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Announces-Board-Refreshment/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Responds-to-13D-Filing/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecise-Antibodies-Invites-Investors-and-Stakeholders-to-Exclusive-Interview-with-Market-Radius-Research/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fiscal-Year-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Fiscal-Year-End-2023-on-July-7th-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPAs-Subsidiary-BioStrand-Unveils-Use-Case-for-Solving-the-Information-Integration-Dilemma-IID/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Releases-New-HYFT-Powered-In-Silico-Humanization-Platform-Aims-to-Disrupt-the-Transgenic-Animal-Model-Market/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPAs-Subsidiary-BioStrand-Solves-the-Information-Integration-Dilemma-IID-for-Systems-Biology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-to-Present-at-Jefferies-Healthcare-Conference-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecises-Subsidiary-Talem-Enters-into-Exclusive-Research-Collaboration-and-License-Option-Agreement-with-Astellas/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/European-Patent-Office-to-Grant-BioKeys-Patent-Application-for-Foundational-HYFT-Technology/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecise-Presents-Novel-T-Cell-Engaging-Bispecific-Antibodies-Addressing-a-Unique-Oncological-Target-Tropomyosin-Receptor-Kinase-B-Associated-with-Poor-Prognosis-and-Survival-Rates/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/ImmunoPrecise-Antibodies-Subsidiary-Talem-Therapeutics-Announces-a-Multi-Target-AI-Driven-Antibody-Discovery-Collaboration-with-Libera-Bio/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2023/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2023-on-March-16-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2023/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPAs-Subsidiary-BioStrand-Completes-Integration-of-20-Million-Proprietary-Structural-HYFTs-and-Accelerates-in-Silico-Drug-Discovery-Developments/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2023-on-December-15-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPAs-Subsidiary-BioStrand-and-BriaCell-Announce-Artificial-Intelligence-Collaboration-and-License-Agreement-to-Discover-and-Develop-Anti-Cancer-Antibodies/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Antibodies-Ltd--Announces-Voluntary-Delisting-from-TSX-Venture-Exchange/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPAs-Subsidiary-Talem-Therapeutics-Licenses-Antibodies-for-Three-OmniChicken-Derived-Programs/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-Reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2023-09-14-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/NIAID-Confirms-IPAs-PolyTope-TATX-03-Neutralizing-Activity-Against-the-Currently-Spreading-SARS-CoV-2-Variant-BA-2-75-09-14-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2023-on-September-14-2022-09-08-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/Live-Virus-Assays-at-Ludwig-Maximilians-Universitt-Mnchen-Confirm-PolyTopes-Efficacy-Against-SARS-CoV-2-Variants-Including-BA-5-08-29-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fiscal-Year-2022-07-29-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-to-Report-Financial-Results-and-Recent-Business-Highlights-for-Fourth-Quarter-and-Full-Fiscal-Year-2022-on-July-29-2022-07-26-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/Research-Antibodies-Reagents-Market-Global-Forecast-to-2027-ResearchAndMarkets-com-07-22-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/Histopathology-Data-of-Preclinical-Repeated-Dose-Toxicity-Study-and-ex-vivo-Human-Tissue-Cross-Reactivity-TCR-Analysis-Support-Safety-of-IPAs-PolyTope-TATX-03-a-Synergistic-Antibody-Cocktail-against-SARSCoV2-07-12-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPAs-Subsidiary-BioStrand-Secures-Second-VLAIO-Research-Grant-05-09-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/Research-Antibodies-Market-Global-Forecasts-from-2022-to-2027-ResearchAndMarkets-com-04-29-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPAs-Advanced-PolyTope-TATX-03-a-Multi-Antibody-Cocktail-Potently-Prevents-In-Vitro-Infection-of-Cells-by-the-Currently-Dominant-Omicron-Sublineage-BA-2-in-Addition-to-all-Other-Variants-of-Concern-04-20-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-Completes-Acquisition-of-Belgian-Technology-Companies-BioStrand-BioKey-and-BioClue--Adding-Artificial-Intelligence-Driven-Analytics-to-its-Antibody-Discovery-Capabilities-and-Offerings-04-14-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/Antibody-Discovery-Services-and-Platforms-Markets-2035-ResearchAndMarkets-com-04-07-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-Announces-Agreement-to-Acquire-BioStrand-BV--Revolutionizing-Biotherapeutics-with-Methodology-to-Encode-Omics-and-Power-Drug-Development-with-Advanced-Artificial-Intelligence-03-29-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-Fiscal-Year-2022-03-16-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-Selected-to-Work-with-Elektrofi-on-COVID-19-Therapeutic-Delivery-and-Future-Pandemic-Preparation-under-SBIR-Contract-from-Defense-Health-Agency-within-US-Department-of-Defense-03-14-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/IPA-Updates-on-Investigational-New-Drug-IND-Enabling-Program-for-PolyTope-TATX-03-03-09-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Sets-Third-Quarter-Fiscal-2022-Financial-Results-and-Recent-Business-Highlights-Conference-Call-for-Wednesday-March-16th-at-1030-a-m--ET-03-08-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/Immunotherapeutic-PolyTope-from-ImmunoPrecise-IPA-Potently-Neutralizes-the-SARS-CoV-2-Omicron-Variant--Moves-Towards-FDAIND-Submission-01-31-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Relocates-European-Subsidiary-to-LEED-Certified-Campus-to-Continue-to-Advance-its-Antibody-Research-Operations-and-Environmental-Sustainability-01-18-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Antibodies-Announces-Grant-of-Stock-Options-01-17-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/COVID-19-Enzyme-Immuno-AssayEnzyme-Linked-Immunosorbent-Assay-EIAELISA-Medical-Devices-Pipeline-Landscape-Report-2021-ResearchAndMarkets-com-01-17-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Antibodies-Announces-Grant-of-Stock-Options-01-11-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2022/ImmunoPrecise-Antibodies-Announces-Grant-of-Stock-Options-01-03-2022/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Antibodies-and-ChemPartner-Biologics-Announce-PolyTope-TATX-03-Antibody-Cocktail-Manufacturing-Collaboration-12-20-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2022-12-13-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-Fiscal-Year-2022-12-07-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Update-on-its-SARS-CoV-2-PolyTope-Multi-Antibody-Cocktail-Development-Program-11-30-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-to-Present-at-the-Benchmark-Companys-Discovery-One-on-One-Virtual-Video-Investor-Conference-on-Thursday-December-2-2021-11-24-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Global-Research-Antibodies-Market-Share-Size-Trends-Industry-Analysis-Forecast-Report-2021-2028-ResearchAndMarkets-com-11-12-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/IPA-Announces-Resignation-of-Director-11-09-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Announces-At-The-Market-Facility-of-up-to-US50-Million-10-13-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Talem-Therapeutics-Announces-Multi-Target-Antibody-Discovery-Research-Collaboration-With-Pierre-Fabre-10-07-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2022-09-09-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Q3-2021-COVID-19-Economic-Impact-and-Forecasts-for-Gross-Domestic-Product-Tourismtravel-and-Medical-Markets-Forecast-to-2025-ResearchAndMarkets-com-09-09-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecises-Dutch-Subsidiary-Receives-French-Research-Tax-Credit-CIR-Accreditation-09-08-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Announces-Participation-at-the-H-C--Wainwright-23rd-Annual-Global-Investment-Conference-on-September-13-15-2021-Virtual-Conference-09-07-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-First-Quarter-Fiscal-Year-2022-09-03-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Welcomes-Vice-President-of-Client-Relations-and-Vice-President-of-Marketing-to-its-Leadership-Team-Accelerating-Its-Growth-and-Expansion-Plans-08-04-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Full-Fiscal-Year-2021-07-28-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecises-PolyTope-TATX-03-Antibody-Cocktail-Potently-Neutralizes-SARS-CoV-2-Delta-Variant-in-in-vitro-Pseudovirus-Assays-07-22-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-to-Report-Financial-Results-and-Business-Highlights-for-Fiscal-Year-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Eurofins-Discovery-and-ImmunoPrecise-Announce-Collaboration-to-Expand-their-Antibody-Discovery-Platform-06-22-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Histopathology-Preclinical-Data-from-ImmunoPrecises-Polytope-Program-Confirms-Lung-Inflammation-Reduction-06-17-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Preclinical-Data-from-ImmunoPrecises-Drug-Pipeline-to-be-Presented-During-the-BIO-International-Partnering-Event-06-15-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Announces-Appointment-of-Dr--Ilse-Roodink-to-the-Role-of-Chief-Scientific-Officer-and-Resignation-of-Dr--Yasmina-Abdiche-06-02-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Names-Dr--Dion-Neame-to-Strategic-Advisory-Board-05-25-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Moves-SARS-CoV-2-PolyTope-Cocktail-Programs-Path-Toward-IND-Filing-05-20-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Selects-LifeSci-Advisors-as-Investor-Relations-Agent-of-Record-04-21-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/Global-COVID-19-Enzyme-Immuno-AssayEnzyme-Linked-Immunosorbent-Assay-EIAELISA-Medical-Device-Pipeline-Market-Assessment-2020-2021-ResearchAndMarkets-com-04-09-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Launches-TATX-112-Candidate-Antibody-Program-for-the-Treatment-of-Cancer-and-Alzheimers-Disease-04-08-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Identifies-a-Unique-Antibody-23-H7-That-Demonstrates-In-Vivo-Efficacy-an-Alternative-Mechanism-of-Action-and-Binds-all-Tested-SARS-CoV-2-Variants-of-Concern-03-25-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Third-Quarter-of-2021-Fiscal-Year-03-17-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Antibodies-Announces-Results-from-a-Comprehensive-Screening-of-27-Proprietary-Anti-SARS-CoV-2-Therapeutic-Antibodies-03-16-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Announces-Participation-at-the-H-C--Wainwright-Global-Life-Sciences-Conference-on-March-9-10-2021-Virtual-Conference-03-04-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Announces-Data-from-Preclinical-Study-of-TATX-03-PolyTope-Monoclonal-Antibody-Cocktail-Candidate-Against-COVID-19-02-19-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/IPA-Announces-Closing-of-Over-Allotment-Option-Associated-with-the-Recently-Completed-Bought-Deal-Offering-of-Common-Shares-02-10-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/IPA-Announces-Closing-of-21-7-Million-Bought-Deal-Offering-of-Common-Shares-02-08-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/IPA-Increases-Previously-Announced-Bought-Deal-Offering-of-Common-Shares-to-21-7-Million-02-03-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/IPA-Announces-10-0-Million-Bought-Deal-Offering-of-Common-Shares-02-03-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Antibodies-to-Participate-in-January-Conferences-01-06-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2021/ImmunoPrecise-Antibodies-Announces-Grant-of-Stock-Options-01-06-2021/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Partners-on-Launch-of-SARS-CoV-2-Nanomedicine-Therapy-Program-12-30-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-to-Begin-Trading-on-Nasdaq-Stock-Exchange-12-23-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Reports-Financial-Results-and-Recent-Business-Highlights-for-Second-Quarter-of-2021-Fiscal-Year-12-21-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Collaboration-Enables-Preclinical-Manufacturing-of-Lead-Antibodies-Targeting-SARS-CoV-2-12-11-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Updated-COVID-19-Economic-Impact-and-Market-Forecasts-for-Gross-Domestic-Product-TourismTravel-and-Medical-Industries-2020-2025-ResearchAndMarkets-com-12-03-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-Ranked-Number-240-Fastest-Growing-Company-in-North-America-on-Deloittes-2020-Technology-Fast-500-11-25-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Selects-Polytope-Formulations-for-Pre-Clinical-Studies-11-23-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-and-Genmab-Enter-into-a-Technology-Partnership-Targeting-Infectious-Disease-11-19-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-Confirms-Effective-Date-of-Share-Consolidation-11-17-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-Files-Preliminary-Base-Shelf-Prospectus-and-Registration-Statement-11-09-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-to-Complete-Share-Consolidation-in-Preparation-for-Potential-Nasdaq-Listing-11-04-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-and-Mila-Announce-Strategic-AI-Partnership-11-03-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Ligand-Reports-Third-Quarter-2020-Financial-Results-10-30-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Worldwide-Research-Antibodies-Reagents-Industry-to-2025-Featuring-Abcam-Agilent-Technologies-Atlas-Antibodies-Among-Others-ResearchAndMarkets-com-10-30-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-and-Twist-Bioscience-Announce-Collaboration-for-the-Creation-of-Novel-Therapeutic-Products-10-27-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Global-Antibody-Discovery-Services-and-Platforms-Market-2020-2030-by-Service-Offered-Antibody-Discovery-Method-Nature-of-Antibody-Generated-ResearchAndMarkets-com-10-16-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Delivers-Lead-Candidate-Antibodies-from-B-Cell-Select-Platform-for-at-Home-SARS-CoV-2-Diagnostic-Test-10-08-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPAs-CEO-Dr--Jennifer-Bath-to-Appear-Live-Wednesday-on-BNN-Television-10-06-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-CEO-Dr--Jennifer-Bath-Appeared-Live-Sunday-October-4th-on-Fox-Friends-10-05-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Reports-Revenue-of-3-8-Million-and-Adjusted-EBITDA-of-932000-for-the-First-Quarter-of-Fiscal-2021-09-29-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-CEO-Dr--Jennifer-Bath-to-Appear-Live-Today-on-Bloomberg-Television-09-28-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-to-Present-at-the-Virtual-Gravitas-Healthcare-Investor-Day-09-28-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Europe-Significantly-Expands-its-Capabilities-Releasing-its-Second-Generation-B-Cell-Select--09-22-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-New-Multi-Specific-SARS-CoV-2-Antibody-Collaboration-with-Zymeworks-09-17-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Commences-Application-Process-to-Dual-List-on-NASDAQ-09-10-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-Participation-at-the-H-C--Wainwright-22nd-Annual-Global-Investment-Conference-on-September-14-16-2020-Virtual-Conference-09-09-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-CEO-to-Participate-in-Virtual-Panel-New-Approaches-to-COVID-19-Hidden-Breakthroughs-on-Thursday-September-10th-09-08-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-Grants-Stock-Options-09-01-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Reports-Record-Revenues-and-Positive-Adjusted-EBITDA-Fiscal-2020-08-31-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Appoints-New-York-Based-Crescendo-Communications-as-Investor-Relations-and-Corporate-Communications-Advisor-08-13-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Ligand-Reports-Second-Quarter-2020-Financial-Results-08-03-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPAs-Human-Anti-SARS-CoV-2-Therapeutic-Antibodies-Demonstrate-Synergistic-Neutralization-07-31-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Awarded-US1-5M-Bioscience-Innovation-Grant-for-Coronavirus-Research-from-the-North-Dakota-Department-of-Agriculture-07-28-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Announces-Repayment-of-Remaining-2018-Debentures-and-3811205-in-Warrant-Exercises-07-20-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Functional-Human-Antibodies-Targeting-SARS-CoV-2-Discovered-Using-IPAs-Proprietary-B-cell-Select-and-Single-Step-Cloning-Hybridoma-Technologies-07-13-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/IPA-Confirms-Discovery-of-Fully-Human-Potent-Neutralizing-Antibodies-Targeting-SARS-CoV-2-06-29-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Recombinant-SARS-CoV-2-Proteins-Now-Available-For-Research-From-ImmunoPrecises-European-Subsidiary-UPE-06-11-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Collaborates-with-the-NIH-and-Integrated-Biotherapeutics-to-Study-the-Structural-Details-of-Antibodies-with-Therapeutic-Potential-to-Treat-or-Prevent-Coronavirus-Disease-2019-COVID-19-06-04-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/COVID-19-Drug-and-Vaccine-Pipeline-Status-Report-Research-Pre-Clinical-Phase-1-2-3-Drug-Candidates-ResearchAndMarkets-com-05-29-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/NSERC-Awards-Grant-to-Fund-Collaboration-Between-ImmunoPrecise-and-the-University-of-Victoria-for-the-Generation-of-a-Potential-COVID-19-Antibody-Based-Test-in-Canada-that-can-Provide-Real-Time-05-27-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/COVID-19-Clinical-Trials-Guide-Companies-Drugs-Phases-Subjects-Current-Status-and-Outlook-to-2025-ResearchAndMarkets-com-05-27-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Closes-Oversubscribed-Debenture-Financing-05-15-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Increases-Financing-to-2-592-Million-05-15-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/Global-Coronavirus-Vaccines-Pipeline-2020-Featuring-150-Organizations-Vaccines-for-COVID-19-SARS-and-MERS-ResearchAndMarkets-com-05-13-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Increases-Financing-to-2-3-Million-and-Makes-Payment-in-Respect-of-Deferred-Purchase-Price-for-IPA-Europe-and-Immulease-05-08-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-Increases-Discovery-Capabilities-to-Help-Pinpoint-Lead-Drug-Candidates-with-Addition-of-Octet-HTX-05-06-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Updates-on-State-and-Federal-Funding-04-24-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Provides-Updates-on-B-Cell-Select-and-Deep-Display-Programs-for-SARS-CoV-2-Antibody-Discovery-04-17-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Participates-in-Public-Consensus-Statement-from-the-WHO-on-Collaboration-for-Developing-a-COVID-19-Vaccine-04-15-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-Agreement-with-Janssen-04-14-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-Appointment-of-Yasmina-Noubia-Abdiche-Ph-D--as-Chief-Scientific-Officer-04-02-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-Extension-of-Debentures-and-Completion-of-Debt-Settlement-of-Previously-Issued-Debentures-03-31-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecises-Artificial-Intelligence-Partner-EVQLV-Submits-First-Panel-of-Optimized-Antibody-Sequences-to-Coronavirus-for-PolyTopeTM-mAb-Therapy-Program-03-30-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-the-Launch-of-PolyTope-mAb-Therapy-to-Tackle-Coronavirus-Pandemic-03-12-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Reports-Record-Quarterly-and-Nine-Month-Revenue-and-Positive-Adjusted-EBITDA-03-10-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-Debt-Settlement-of-Previously-Issued-Debentures-03-06-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Announces-Artificial-Intelligence-Collaboration-with-EVQLV-to-Accelerate-Vaccine-and-Antibody-Discovery-for-SARS-CoV-2-Coronavirus-03-02-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Launches-Coronavirus-Vaccine-and-Therapeutic-Antibody-Program-02-20-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-integrates-SGI-DNAs-benchtop-automated-DNA-printer-to-accelerate-antibody-discovery-and-manufacturing-services-01-20-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Subsidiary-Joins-Genmab-and-Merus-in-Expansion-to-new-Biotech-Accelerator-at-the-Center-of-Europes-Most-Competitive-Science-Region-01-09-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2020/ImmunoPrecise-Antibodies-Will-Be-in-San-Francisco-During-J-P--Morgan-Healthcare-Conference-Week-January-13-16-2020-01-06-2020/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Announces-Record-Quarterly-Revenue-and-Significantly-Expands-Gross-Margins-12-17-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Announces-Annual-General-Meeting-Results-12-02-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/Talem-Therapeutics-accesses-the-OmniAb-platform-from-Ligand-Pharmaceuticals-11-05-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Adopts-Shareholder-Rights-Plan-10-18-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Strengthens-Board-of-Directors-with-Antibody-Business-Leader-Brian-Lundstrom-10-03-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Appoints-Biotech-Industry-Executive-Dr--Stefan-Lang-as-Chief-Business-Officer-10-01-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Announces-95-7-Investors-Favored-Debenture-Extension-and-Q1-2020-Financial-Results-09-30-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecises-Talem-Therapeutics-Enters-into-an-LOI-with-AgonOx-Pharma-in-the-Advancement-of-Novel-Immuno-Oncology-Therapeutics-09-24-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Launches-Abthena-Bispecific-Platform-And-Artemis-Intelligence-Metadata-AIM-09-23-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Annual-Revenues-Increase-100-to-10926268-Million-08-28-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecises-Wholly-Owned-Talem-Therapeutics-Announces-the-Creation-of-its-Scientific-Committee-08-01-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Announces-Immuno-oncology-Discovery-Collaboration-with-Entos-Pharmaceuticals-07-15-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Guarantees-Success-for-Customers-of-Their-Well-Established-B-cell-Select-Antibody-Discovery-Platform-06-26-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Announces-an-Unprecedented-Onboarding-of-Pharma-and-Biotech-Clients-Using-IPAs-Proprietary-High-Throughput-B-Cell-Select-and-DeepDisplay-05-30-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Subsidiary-U-Protein-Express-Announces-Exclusive-Agreement-as-Global-Supplier-for-Wnt-Surrogate-Fc-Growth-Factor-04-25-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-to-Present-at-the-2019-Bloom-Burton-Co--Healthcare-Investor-Conference-04-16-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Appoints-Andy-Nixon-to-Board-of-Directors-04-11-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/TetraGenetics-and-ImmunoPrecise-extend-collaboration-by-signing-multi-target-service-agreement-for-the-Discovery-of-Therapeutic-Antibodies-04-09-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Leverages-Proprietary-Technology-and-Expertise-to-Create-Talem-Therapeutics-04-04-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Ltd--Announces-Trading-on-OTCQB-Venture-Market-04-03-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Launches-DeepDisplay-Antibody-Discovery-Platform-04-02-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Reports-Record-Q3-2019-Financials-Results-03-27-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Announces-Resignation-of-Jos-Raats-as-Managing-Director-of-ModiQuest-Research-BV-03-15-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Announces-DTC-Eligibility-02-28-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Receives-Subcontract-to-Produce-Rabbit-Monoclonal-Antibodies-02-21-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Collaborates-with-FIND-to-Help-Advance-New-TB-Diagnostic-Test-02-19-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/Second-US-Office-for-ImmunoPrecise-Antibodies-Ltd--in-Cambridge-Massachusetts-02-14-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Ltd--Increases-Antibody-Discovery-Capabilities-with-Addition-of-Integrated-Laboratory-Equipment-for-High-throughput-Antibody-Screening-02-05-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Appoints-Lisa-Helbling-as-Chief-Financial-Officer-01-14-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2019/ImmunoPrecise-Antibodies-Will-Be-in-San-Francisco-During-J-P--Morgan-Healthcare-Conference-Week-January-7-10-2019-01-03-2019/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/Immunoprecise-Doubles-Q2-Revenue-From-Q2-2017-12-31-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Hires-Jason-Orloske-as-Vice-President-Operations-12-26-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Announces-Results-of-Annual-General-Meeting-11-21-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ModiQuest-to-Offer-Ligands-OmniAb-Service-in-Europe-10-15-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Signs-Large-Pharma-Antibody-Development-Agreement-10-09-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Announces-Phage-Display-Based-Antibody-Discovery-Platforms-10-02-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Antibodies-Q1-Revenues-Increase-386-Over-Q1-2017-10-01-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Closes-Oversubscribed-Private-Placement-Raising-9-1M-09-28-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/The-Centre-for-Drug-Research-and-Development-CDRD-selected-ImmunoPrecises-Chief-Scientific-Officer-Dr--Deanna-Dryhurst-as-member-of-the-CDRD-Academy-Executive-Institute--09-21-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Antibodies-Annual-Revenues-Increase-106-to-5-4-Million-08-29-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Increases-Private-Placement-Financing-to-7-Million-08-28-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Announces-2-Million-Financing-08-22-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2018/ImmunoPrecise-Announces-the-Resignation-of-Director-08-20-2018/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/news/news-releases/news-details/2017/Ligand-Reports-Third-Quarter-2017-Financial-Results-11-09-2017/default.aspx hourly 2026-08-17T09:52:24-04:00 https://ir.mindwalkai.com/overview/default.aspx hourly 2026-09-22T01:03:07-04:00 https://ir.mindwalkai.com/news/default.aspx hourly 2026-08-17T03:51:02-04:00 https://ir.mindwalkai.com/events-and-presentations/default.aspx hourly 2026-08-17T03:51:02-04:00 https://ir.mindwalkai.com/governance/governance-documents/default.aspx hourly 2025-01-15T01:59:29-05:00 https://ir.mindwalkai.com/stock-info/stock-quote/default.aspx hourly 2025-06-23T03:02:54-04:00 https://ir.mindwalkai.com/financials/quarterly-results/default.aspx hourly 2026-08-14T08:40:55-04:00 https://ir.mindwalkai.com/resources/information-request-form/default.aspx hourly 2024-02-14T11:46:56-05:00 https://ir.mindwalkai.com/financials/annual-reports/default.aspx hourly 2024-02-14T11:46:57-05:00 https://ir.mindwalkai.com/governance/executive-management/default.aspx hourly 2025-01-15T01:59:29-05:00 https://ir.mindwalkai.com/resources/investor-email-alerts/default.aspx hourly 2024-02-14T11:46:56-05:00 https://ir.mindwalkai.com/financials/sec-filings/default.aspx hourly 2024-02-14T11:46:57-05:00 https://ir.mindwalkai.com/governance/board-of-directors/default.aspx hourly 2025-01-15T01:59:29-05:00 https://ir.mindwalkai.com/resources/investor-contacts/default.aspx hourly 2024-02-14T11:46:56-05:00 https://ir.mindwalkai.com/governance/committee-composition/default.aspx hourly 2025-01-15T01:59:29-05:00 https://ir.mindwalkai.com/stock-info/analyst-coverage/default.aspx hourly 2024-02-14T11:46:56-05:00 https://ir.mindwalkai.com/news/news-releases/default.aspx hourly 2026-08-17T03:51:02-04:00 https://ir.mindwalkai.com/news/in-the-media/default.aspx hourly 2026-08-17T03:51:02-04:00